Xencor, Inc. (XNCR)
34.39
-0.11
(-0.32%)
USD |
NASDAQ |
Nov 18, 16:00
34.40
+0.01
(+0.03%)
After-Hours: 07:43
Xencor Enterprise Value : 2.326B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 2.326B |
| November 17, 2026 | 2.334B |
| November 16, 2026 | 2.402B |
| November 13, 2026 | 2.528B |
| November 12, 2026 | 2.606B |
| November 11, 2026 | 2.743B |
| November 10, 2026 | 2.700B |
| November 09, 2026 | 2.640B |
| November 06, 2026 | 2.428B |
| November 05, 2026 | 2.301B |
| November 04, 2026 | 2.374B |
| November 03, 2026 | 2.046B |
| November 02, 2026 | 1.973B |
| October 30, 2026 | 1.985B |
| October 29, 2026 | 1.939B |
| October 28, 2026 | 1.997B |
| October 27, 2026 | 1.997B |
| October 26, 2026 | 1.937B |
| October 23, 2026 | 1.638B |
| October 22, 2026 | 1.687B |
| October 21, 2026 | 1.636B |
| October 20, 2026 | 1.620B |
| October 19, 2026 | 1.489B |
| October 16, 2026 | 1.463B |
| October 15, 2026 | 1.549B |
| Date | Value |
|---|---|
| October 14, 2026 | 1.504B |
| October 13, 2026 | 1.514B |
| October 12, 2026 | 1.627B |
| October 09, 2026 | 1.597B |
| October 08, 2026 | 1.587B |
| October 07, 2026 | 1.569B |
| October 06, 2026 | 1.576B |
| October 05, 2026 | 1.671B |
| October 02, 2026 | 1.612B |
| October 01, 2026 | 1.607B |
| September 30, 2026 | 1.620B |
| September 29, 2026 | 1.572B |
| September 28, 2026 | 1.616B |
| September 25, 2026 | 1.483B |
| September 24, 2026 | 1.489B |
| September 23, 2026 | 1.517B |
| September 22, 2026 | 1.584B |
| September 21, 2026 | 1.574B |
| September 18, 2026 | 1.551B |
| September 17, 2026 | 1.541B |
| September 16, 2026 | 1.476B |
| September 15, 2026 | 1.479B |
| September 14, 2026 | 1.537B |
| September 11, 2026 | 1.528B |
| September 10, 2026 | 1.517B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Iovance Biotherapeutics, Inc. | 3.129B |
| Ironwood Pharmaceuticals, Inc. | 1.041B |
| UroGen Pharma Ltd. | 1.565B |
| MeiraGTx Holdings Plc | 761.54M |
| IDEAYA Biosciences, Inc. | 1.751B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 39.44M |
| Revenue (Quarterly) | 116.52M |
| Total Expenses (Quarterly) | 77.08M |
| EPS Diluted (Quarterly) | 0.5033 |
| Gross Profit Margin (Quarterly) | 98.08% |
| Profit Margin (Quarterly) | 33.84% |
| Earnings Yield | -4.61% |
| Normalized Earnings Yield | -4.832 |